US Stock MarketDetailed Quotes

Arcutis Biotherapeutics (ARQT)

Watchlist
  • 20.660
  • -3.510-14.52%
Close May 7 15:59 ET
  • 20.810
  • +0.150+0.73%
Pre 08:04 ET
2.58BMarket Cap-1033.00P/E (TTM)

Arcutis Biotherapeutics (ARQT) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
107.37%2.24M
94.98%-5.63M
3,600.67%26.19M
94.94%-1.75M
100.72%324K
3.87%-30.38M
54.60%-112.16M
98.67%-748K
21.13%-34.69M
32.14%-45.12M
Net income from continuing operations
54.93%-11.3M
88.47%-16.14M
261.24%17.4M
117.84%7.41M
69.64%-15.89M
29.17%-25.06M
46.58%-140.04M
83.72%-10.79M
7.21%-41.54M
26.28%-52.33M
Operating gains losses
----
----
----
----
----
61.33%-210K
-132.86%-279K
--150K
--226K
---112K
Depreciation and amortization
-81.13%562K
138.23%4.67M
79.87%563K
-55.78%562K
3,211.76%563K
732.12%2.98M
161.20%1.96M
181.09%313K
228.42%1.27M
-95.60%17K
Other non cash items
43.92%675K
-60.99%2.41M
-83.92%482K
-43.26%732K
-7.64%725K
-57.40%469K
2.71%6.17M
9.78%3M
16.53%1.29M
-28.11%785K
Change In working capital
110.11%1.79M
-130.96%-34.83M
-48.44%-2.33M
-424.29%-19.94M
220.18%5.13M
-225.01%-17.69M
35.83%-15.08M
-481.27%-1.57M
58.56%-3.8M
25.48%-4.27M
-Change in receivables
115.00%1.85M
-54.81%-73.16M
-120.25%-31.11M
49.25%-8.43M
-310.89%-21.27M
-8.83%-12.35M
-172.40%-47.26M
-121.06%-14.13M
-651.54%-16.61M
-16.65%-5.18M
-Change in inventory
-647.26%-14.58M
-1,732.25%-7.33M
98.11%-5K
-1,064.16%-5.89M
181.83%518K
-1,626.55%-1.95M
92.88%-400K
-134.02%-265K
117.77%611K
67.08%-633K
-Change in prepaid assets
-257.34%-11.73M
-111.71%-2.01M
-1,816.67%-1.27M
58.60%-1.76M
298.25%4.3M
-159.26%-3.28M
89.00%-948K
-104.50%-66K
50.53%-4.25M
-335.50%-2.17M
-Change in payables and accrued expense
27,669.47%26.38M
41.12%48.35M
130.79%30.18M
-122.33%-3.71M
459.48%21.79M
-85.61%95K
291.74%34.26M
176.84%13.08M
218.16%16.63M
3,291.80%3.89M
-Change in other current liabilities
31.50%-137K
7.48%-680K
32.98%-126K
18.92%-150K
-12.09%-204K
-11.11%-200K
-11.87%-735K
-11.90%-188K
-12.12%-185K
-10.98%-182K
Cash from discontinued investing activities
Operating cash flow
107.37%2.24M
94.98%-5.63M
3,600.67%26.19M
94.94%-1.75M
100.72%324K
3.87%-30.38M
54.60%-112.16M
98.67%-748K
21.13%-34.69M
32.14%-45.12M
Investing cash flow
Cash flow from continuing investing activities
-196.44%-11.33M
-204.97%-30.25M
-198.00%-34.18M
-129.78%-25.25M
128.04%17.42M
140.95%11.75M
-84.01%28.82M
156.08%34.88M
86.12%84.78M
-169.72%-62.14M
Net PPE purchase and sale
--0
-379.72%-686K
--0
--0
---78K
---608K
66.59%-143K
--0
-123.44%-143K
--0
Net intangibles purchase and sale
----
-100.00%-10M
--0
--0
----
----
---5M
---5M
--0
----
Net investment purchase and sale
-191.70%-11.33M
-157.61%-19.57M
-185.71%-34.18M
-129.73%-25.25M
144.26%27.5M
143.06%12.36M
-81.20%33.96M
164.13%39.88M
86.17%84.92M
-169.51%-62.14M
Cash from discontinued investing activities
Investing cash flow
-196.44%-11.33M
-204.97%-30.25M
-198.00%-34.18M
-129.78%-25.25M
128.04%17.42M
140.95%11.75M
-84.01%28.82M
156.08%34.88M
86.12%84.78M
-169.72%-62.14M
Financing cash flow
Cash flow from continuing financing activities
170.13%1.07M
-89.47%6.97M
103.82%3.72M
274.62%1.48M
-5.15%1.38M
-99.76%395K
-34.66%66.2M
-198.11%-97.41M
-54.56%394K
36.36%1.46M
Net issuance payments of debt
----
--0
----
----
----
----
---100M
----
----
----
Net common stock issuance
----
--0
--0
--0
--0
--0
63.48%161.68M
--0
--0
--0
Proceeds from stock option exercised by employees
170.13%1.07M
54.27%6.97M
43.76%3.72M
274.62%1.48M
-5.15%1.38M
381.71%395K
86.62%4.52M
567.27%2.59M
-54.56%394K
36.36%1.46M
Cash from discontinued financing activities
Financing cash flow
170.13%1.07M
-89.47%6.97M
103.82%3.72M
274.62%1.48M
-5.15%1.38M
-99.76%395K
-34.66%66.2M
-198.11%-97.41M
-54.56%394K
36.36%1.46M
Net cash flow
Beginning cash position
-39.94%43.22M
-19.45%71.95M
-64.99%47.43M
-13.95%73.05M
-71.83%53.72M
-19.45%71.95M
62.78%89.32M
24.98%135.47M
-19.95%84.89M
131.65%190.71M
Current changes in cash
55.99%-8.03M
-68.68%-28.91M
93.25%-4.27M
-150.56%-25.53M
118.08%19.13M
-117.97%-18.24M
-149.67%-17.14M
-230.61%-63.28M
1,975.78%50.48M
-546.42%-105.8M
Effect of exchange rate changes
-3,075.00%-119K
171.49%168K
125.21%59K
-196.94%-95K
869.23%200K
105.48%4K
-370.00%-235K
-444.12%-234K
230.67%98K
-388.89%-26K
End cash Position
-34.72%35.07M
-39.94%43.22M
-39.94%43.22M
-64.99%47.43M
-13.95%73.05M
-71.83%53.72M
-19.45%71.95M
-19.45%71.95M
24.98%135.47M
-19.95%84.89M
Free cash flow
107.23%2.24M
86.09%-16.31M
555.55%26.19M
94.96%-1.75M
78.38%-9.75M
1.95%-30.99M
52.60%-117.3M
89.78%-5.75M
20.92%-34.83M
32.42%-45.12M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 107.37%2.24M94.98%-5.63M3,600.67%26.19M94.94%-1.75M100.72%324K3.87%-30.38M54.60%-112.16M98.67%-748K21.13%-34.69M32.14%-45.12M
Net income from continuing operations 54.93%-11.3M88.47%-16.14M261.24%17.4M117.84%7.41M69.64%-15.89M29.17%-25.06M46.58%-140.04M83.72%-10.79M7.21%-41.54M26.28%-52.33M
Operating gains losses --------------------61.33%-210K-132.86%-279K--150K--226K---112K
Depreciation and amortization -81.13%562K138.23%4.67M79.87%563K-55.78%562K3,211.76%563K732.12%2.98M161.20%1.96M181.09%313K228.42%1.27M-95.60%17K
Other non cash items 43.92%675K-60.99%2.41M-83.92%482K-43.26%732K-7.64%725K-57.40%469K2.71%6.17M9.78%3M16.53%1.29M-28.11%785K
Change In working capital 110.11%1.79M-130.96%-34.83M-48.44%-2.33M-424.29%-19.94M220.18%5.13M-225.01%-17.69M35.83%-15.08M-481.27%-1.57M58.56%-3.8M25.48%-4.27M
-Change in receivables 115.00%1.85M-54.81%-73.16M-120.25%-31.11M49.25%-8.43M-310.89%-21.27M-8.83%-12.35M-172.40%-47.26M-121.06%-14.13M-651.54%-16.61M-16.65%-5.18M
-Change in inventory -647.26%-14.58M-1,732.25%-7.33M98.11%-5K-1,064.16%-5.89M181.83%518K-1,626.55%-1.95M92.88%-400K-134.02%-265K117.77%611K67.08%-633K
-Change in prepaid assets -257.34%-11.73M-111.71%-2.01M-1,816.67%-1.27M58.60%-1.76M298.25%4.3M-159.26%-3.28M89.00%-948K-104.50%-66K50.53%-4.25M-335.50%-2.17M
-Change in payables and accrued expense 27,669.47%26.38M41.12%48.35M130.79%30.18M-122.33%-3.71M459.48%21.79M-85.61%95K291.74%34.26M176.84%13.08M218.16%16.63M3,291.80%3.89M
-Change in other current liabilities 31.50%-137K7.48%-680K32.98%-126K18.92%-150K-12.09%-204K-11.11%-200K-11.87%-735K-11.90%-188K-12.12%-185K-10.98%-182K
Cash from discontinued investing activities
Operating cash flow 107.37%2.24M94.98%-5.63M3,600.67%26.19M94.94%-1.75M100.72%324K3.87%-30.38M54.60%-112.16M98.67%-748K21.13%-34.69M32.14%-45.12M
Investing cash flow
Cash flow from continuing investing activities -196.44%-11.33M-204.97%-30.25M-198.00%-34.18M-129.78%-25.25M128.04%17.42M140.95%11.75M-84.01%28.82M156.08%34.88M86.12%84.78M-169.72%-62.14M
Net PPE purchase and sale --0-379.72%-686K--0--0---78K---608K66.59%-143K--0-123.44%-143K--0
Net intangibles purchase and sale -----100.00%-10M--0--0-----------5M---5M--0----
Net investment purchase and sale -191.70%-11.33M-157.61%-19.57M-185.71%-34.18M-129.73%-25.25M144.26%27.5M143.06%12.36M-81.20%33.96M164.13%39.88M86.17%84.92M-169.51%-62.14M
Cash from discontinued investing activities
Investing cash flow -196.44%-11.33M-204.97%-30.25M-198.00%-34.18M-129.78%-25.25M128.04%17.42M140.95%11.75M-84.01%28.82M156.08%34.88M86.12%84.78M-169.72%-62.14M
Financing cash flow
Cash flow from continuing financing activities 170.13%1.07M-89.47%6.97M103.82%3.72M274.62%1.48M-5.15%1.38M-99.76%395K-34.66%66.2M-198.11%-97.41M-54.56%394K36.36%1.46M
Net issuance payments of debt ------0-------------------100M------------
Net common stock issuance ------0--0--0--0--063.48%161.68M--0--0--0
Proceeds from stock option exercised by employees 170.13%1.07M54.27%6.97M43.76%3.72M274.62%1.48M-5.15%1.38M381.71%395K86.62%4.52M567.27%2.59M-54.56%394K36.36%1.46M
Cash from discontinued financing activities
Financing cash flow 170.13%1.07M-89.47%6.97M103.82%3.72M274.62%1.48M-5.15%1.38M-99.76%395K-34.66%66.2M-198.11%-97.41M-54.56%394K36.36%1.46M
Net cash flow
Beginning cash position -39.94%43.22M-19.45%71.95M-64.99%47.43M-13.95%73.05M-71.83%53.72M-19.45%71.95M62.78%89.32M24.98%135.47M-19.95%84.89M131.65%190.71M
Current changes in cash 55.99%-8.03M-68.68%-28.91M93.25%-4.27M-150.56%-25.53M118.08%19.13M-117.97%-18.24M-149.67%-17.14M-230.61%-63.28M1,975.78%50.48M-546.42%-105.8M
Effect of exchange rate changes -3,075.00%-119K171.49%168K125.21%59K-196.94%-95K869.23%200K105.48%4K-370.00%-235K-444.12%-234K230.67%98K-388.89%-26K
End cash Position -34.72%35.07M-39.94%43.22M-39.94%43.22M-64.99%47.43M-13.95%73.05M-71.83%53.72M-19.45%71.95M-19.45%71.95M24.98%135.47M-19.95%84.89M
Free cash flow 107.23%2.24M86.09%-16.31M555.55%26.19M94.96%-1.75M78.38%-9.75M1.95%-30.99M52.60%-117.3M89.78%-5.75M20.92%-34.83M32.42%-45.12M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
On May 7 Eastern Time, as the US-Iran negotiations entered a critical window amid external expectations and various parties' strategic maneu Show More